DIS3L2 and Nephroblastoma: RNA-seq analysis over DIS3L2-null nephron progenitor cells from mouse, which serves as model for Wilms tumor research, revealed another DIS3L2 target, the insulin growth factor 2 (IGF2) [15] that has been reported as an oncogene driving Wilms tumorigenesis [16].